{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:44:45Z","timestamp":1792007085385,"version":"4.4.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,15]]},"DOI":"10.7759\/cureus.107120","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T23:18:21Z","timestamp":1776295101000},"source":"Crossref","is-referenced-by-count":2,"title":["A Developmental Taxonomy of Autism and the Precision Timing of the Cheung Glutamatergic Regimen"],"prefix":"10.7759","author":[{"given":"Ngo","family":"Cheung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0138-4","article-title":"Autism spectrum disorder","volume":"6","author":"Lord C","year":"2020","unstructured":"Lord C, Brugha TS, Charman T, et al.. Autism spectrum disorder. Nat Rev Dis Primers. 2020, 6:5. 10.1038\/s41572-019-0138-4","journal-title":"Nat Rev Dis Primers"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/jcpp.13505","article-title":"Time trends in autism diagnosis over 20 years: a UK population-based cohort study","volume":"63","author":"Russell G","year":"2022","unstructured":"Russell G, Stapley S, Newlove-Delgado T, et al.. Time trends in autism diagnosis over 20 years: a UK population-based cohort study. J Child Psychol Psychiatry. 2022, 63:674-82. 10.1111\/jcpp.13505","journal-title":"J Child Psychol Psychiatry"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-09542-6","article-title":"Polygenic and developmental profiles of autism differ by age at diagnosis","volume":"646","author":"Zhang X","year":"2025","unstructured":"Zhang X, Grove J, Gu Y, et al.. Polygenic and developmental profiles of autism differ by age at diagnosis. Nature. 2025, 646:1146-55. 10.1038\/s41586-025-09542-6","journal-title":"Nature"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.6084\/m9.figshare.31437283.v1","article-title":"Divergent synaptic plasticity and pruning mechanisms underlie early- versus late-diagnosed autism: evidence from a transcriptome-wide association study [PREPRINT]","author":"Cheung N","year":"2026","unstructured":"Cheung N. Divergent synaptic plasticity and pruning mechanisms underlie early- versus late-diagnosed autism: evidence from a transcriptome-wide association study [PREPRINT]. figshare. 2026, 10.6084\/m9.figshare.31437283.v1","journal-title":"figshare"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.6084\/m9.figshare.31441063.v1","article-title":"\"Build versus refine\": transcriptomic mapping of ADHD aligns selectively with late-diagnosed autism at LRRK2- and pruning-mediated pathways [PREPRINT]","author":"Cheung N","year":"2026","unstructured":"Cheung N. \"Build versus refine\": transcriptomic mapping of ADHD aligns selectively with late-diagnosed autism at LRRK2- and pruning-mediated pathways [PREPRINT]. figshare. 2026, 10.6084\/m9.figshare.31441063.v1","journal-title":"figshare"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-022-01285-8","article-title":"Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains","volume":"55","author":"Demontis D","year":"2023","unstructured":"Demontis D, Walters GB, Athanasiadis G, et al.. Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains. Nat Genet. 2023, 55:198-208. 10.1038\/s41588-022-01285-8","journal-title":"Nat Genet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/jcpp.13587","article-title":"Mental health and social difficulties of late-diagnosed autistic children, across childhood and adolescence","volume":"63","author":"Mandy W","year":"2022","unstructured":"Mandy W, Midouhas E, Hosozawa M, Cable N, Sacker A, Flouri E. Mental health and social difficulties of late-diagnosed autistic children, across childhood and adolescence. J Child Psychol Psychiatry. 2022, 63:1405-14. 10.1111\/jcpp.13587","journal-title":"J Child Psychol Psychiatry"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2014.07.040","article-title":"Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits","volume":"83","author":"Tang G","year":"2014","unstructured":"Tang G, Gudsnuk K, Kuo SH, et al.. Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits. Neuron. 2014, 83:1131-43. 10.1016\/j.neuron.2014.07.040","journal-title":"Neuron"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-024-02776-2","article-title":"(11)C-UCB-J PET imaging is consistent with lower synaptic density in autistic adults","volume":"30","author":"Matuskey D","year":"2025","unstructured":"Matuskey D, Yang Y, Naganawa M, et al.. (11)C-UCB-J PET imaging is consistent with lower synaptic density in autistic adults. Mol Psychiatry. 2025, 30:1610-6. 10.1038\/s41380-024-02776-2","journal-title":"Mol Psychiatry"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.20944\/preprints202511.1815.v1","article-title":"DXM, CYP2D6-inhibiting antidepressants, piracetam, and glutamine: proposing a ketamine-class antidepressant regimen with existing drugs [PREPRINT]","author":"Cheung N","year":"2025","unstructured":"Cheung N. DXM, CYP2D6-inhibiting antidepressants, piracetam, and glutamine: proposing a ketamine-class antidepressant regimen with existing drugs [PREPRINT]. Preprints.org. 2025, 10.20944\/preprints202511.1815.v1","journal-title":"Preprints.org"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li N","year":"2010","unstructured":"Li N, Lee B, Liu RJ, et al.. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science. 2010, 329:959-64. 10.1126\/science.1190287","journal-title":"Science"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2007.05.028","article-title":"Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors","volume":"63","author":"Maeng S","year":"2008","unstructured":"Maeng S, Zarate CA Jr, Du J, Schloesser RJ, McCammon J, Chen G, Manji HK. Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biol Psychiatry. 2008, 63:349-52. 10.1016\/j.biopsych.2007.05.028","journal-title":"Biol Psychiatry"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2010.136","article-title":"Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis","volume":"17","author":"Rossignol DA","year":"2012","unstructured":"Rossignol DA, Frye RE. Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Mol Psychiatry. 2012, 17:290-314. 10.1038\/mp.2010.136","journal-title":"Mol Psychiatry"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.3.337","article-title":"Evidence of brain overgrowth in the first year of life in autism","volume":"290","author":"Courchesne E","year":"2003","unstructured":"Courchesne E, Carper R, Akshoomoff N. Evidence of brain overgrowth in the first year of life in autism. JAMA. 2003, 290:337-44. 10.1001\/jama.290.3.337","journal-title":"JAMA"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2024.1431693","article-title":"Head circumference growth in children with Autism Spectrum Disorder: trend and clinical correlates in the first five years of life","volume":"15","author":"Cirnigliaro L","year":"2024","unstructured":"Cirnigliaro L, Cleric\u00f2 L, Russo LC, Prato A, Caruso M, Rizzo R, Barone R. Head circumference growth in children with Autism Spectrum Disorder: trend and clinical correlates in the first five years of life. Front Psychiatry. 2024, 15:1431693. 10.3389\/fpsyt.2024.1431693","journal-title":"Front Psychiatry"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4103\/NRR.NRR-D-24-01422","article-title":"Mitochondrial dynamics dysfunction and neurodevelopmental disorders: From pathological mechanisms to clinical translation","volume":"21","author":"Yang Z","year":"2026","unstructured":"Yang Z, Luo Y, Yang Z, et al.. Mitochondrial dynamics dysfunction and neurodevelopmental disorders: From pathological mechanisms to clinical translation. Neural Regen Res. 2026, 21:1926-46. 10.4103\/NRR.NRR-D-24-01422","journal-title":"Neural Regen Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.12263","article-title":"IL-1\u03b2 and TNF-\u03b1 induce neurotoxicity through glutamate production: a potential role for neuronal glutaminase","volume":"125","author":"Ye L","year":"2013","unstructured":"Ye L, Huang Y, Zhao L, et al.. IL-1\u03b2 and TNF-\u03b1 induce neurotoxicity through glutamate production: a potential role for neuronal glutaminase. J Neurochem. 2013, 125:897-908. 10.1111\/jnc.12263","journal-title":"J Neurochem"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01081-0","article-title":"Signalling pathways in autism spectrum disorder: mechanisms and therapeutic implications","volume":"7","author":"Jiang CC","year":"2022","unstructured":"Jiang CC, Lin LS, Long S, Ke XY, Fukunaga K, Lu YM, Han F. Signalling pathways in autism spectrum disorder: mechanisms and therapeutic implications. Signal Transduct Target Ther. 2022, 7:229. 10.1038\/s41392-022-01081-0","journal-title":"Signal Transduct Target Ther"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-38306-3","article-title":"Increased glutamate and glutamine levels and their relationship to astrocytes and dopaminergic transmissions in the brains of adults with autism","volume":"13","author":"Oya M","year":"2023","unstructured":"Oya M, Matsuoka K, Kubota M, et al.. Increased glutamate and glutamine levels and their relationship to astrocytes and dopaminergic transmissions in the brains of adults with autism. Sci Rep. 2023, 13:11655. 10.1038\/s41598-023-38306-3","journal-title":"Sci Rep"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1125428","article-title":"Microglia and astrocytes underlie neuroinflammation and synaptic susceptibility in autism spectrum disorder","volume":"17","author":"Xiong Y","year":"2023","unstructured":"Xiong Y, Chen J, Li Y. Microglia and astrocytes underlie neuroinflammation and synaptic susceptibility in autism spectrum disorder. Front Neurosci. 2023, 17:1125428. 10.3389\/fnins.2023.1125428","journal-title":"Front Neurosci"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.840266","article-title":"Complement dependent synaptic reorganisation during critical periods of brain development and risk for psychiatric disorder","volume":"16","author":"Westacott LJ","year":"2022","unstructured":"Westacott LJ, Wilkinson LS.  Complement dependent synaptic reorganisation during critical periods of brain development and risk for psychiatric disorder. Front Neurosci. 2022, 16:840266. 10.3389\/fnins.2022.840266","journal-title":"Front Neurosci"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9010274","article-title":"Comparative genomic mapping implicates LRRK2 for intellectual disability and autism at 12q12","volume":"9","author":"Labonne JD","year":"2020","unstructured":"Labonne JD, Driessen TM, Harris ME, et al.. Comparative genomic mapping implicates LRRK2 for intellectual disability and autism at 12q12. J Clin Med. 2020, 9:274. 10.3390\/jcm9010274","journal-title":"J Clin Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3730-10.2011","article-title":"LRRK2 controls synaptic vesicle storage and mobilization within the recycling pool","volume":"31","author":"Piccoli G","year":"2011","unstructured":"Piccoli G, Condliffe SB, Bauer M, et al.. LRRK2 controls synaptic vesicle storage and mobilization within the recycling pool. J Neurosci. 2011, 31:2225-37. 10.1523\/JNEUROSCI.3730-10.2011","journal-title":"J Neurosci"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2217\/bmm.14.15","article-title":"\u03b3-band abnormalities as markers of autism spectrum disorders","volume":"8","author":"Rojas DC","year":"2014","unstructured":"Rojas DC, Wilson LB. \u03b3-band abnormalities as markers of autism spectrum disorders. Biomark Med. 2014, 8:353-68. 10.2217\/bmm.14.15","journal-title":"Biomark Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2024.116040","article-title":"Alterations in resting-state gamma-activity is adults with autism spectrum disorder: A High-Density EEG study","volume":"339","author":"Kakuszi B","year":"2024","unstructured":"Kakuszi B, Szuromi B, T\u00f3th M, Bitter I, Czobor P. Alterations in resting-state gamma-activity is adults with autism spectrum disorder: A High-Density EEG study. Psychiatry Res. 2024, 339:116040. 10.1016\/j.psychres.2024.116040","journal-title":"Psychiatry Res"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-023-02681-2","article-title":"Resting-state EEG power differences in autism spectrum disorder: a systematic review and meta-analysis","volume":"13","author":"Neo WS","year":"2023","unstructured":"Neo WS, Foti D, Keehn B, Kelleher B. Resting-state EEG power differences in autism spectrum disorder: a systematic review and meta-analysis. Transl Psychiatry. 2023, 13:389. 10.1038\/s41398-023-02681-2","journal-title":"Transl Psychiatry"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29297","article-title":"LRRK2 Inhibition by BIIB122 in Healthy Participants and Patients with Parkinson's Disease","volume":"38","author":"Jennings D","year":"2023","unstructured":"Jennings D, Huntwork-Rodriguez S, Vissers MF, et al.. LRRK2 Inhibition by BIIB122 in Healthy Participants and Patients with Parkinson's Disease. Mov Disord. 2023, 38:386-98. 10.1002\/mds.29297","journal-title":"Mov Disord"},{"key":"ref28","unstructured":"Neuron23. Neuron23 announces $96.5 million Series D financing and first patient dosed in global Phase 2 NEULARK clinical trial of NEU-411 for early Parkinson\u2019s disease. (2025). Accessed. April 14, 2026: https:\/\/neuron23.com\/neuron23-announces-96-5-million-series-d-financing-and-first-patient-dosed-in-global-phase-2-neu...."},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1017\/neu.2025.10017","article-title":"Complement system dysfunction in autism spectrum disorder: evidence for altered C1q and C3 levels (complement system dysfunction in ASD)","volume":"37","author":"Gunaydin M","year":"2025","unstructured":"Gunaydin M, Dogan O, Gunay F, Cikili-Uytun M, Celik-Buyukceran \u00d6, Oztop DB. Complement system dysfunction in autism spectrum disorder: evidence for altered C1q and C3 levels (complement system dysfunction in ASD). Acta Neuropsychiatr. 2025, 37:e64. 10.1017\/neu.2025.10017","journal-title":"Acta Neuropsychiatr"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26062479","article-title":"A mitochondrial supplement improves function and mitochondrial activity in autism: a double-blind placebo-controlled cross-over trial","volume":"26","author":"Hill Z","year":"2025","unstructured":"Hill Z, McCarty PJ, Boles RG, Frye RE. A mitochondrial supplement improves function and mitochondrial activity in autism: a double-blind placebo-controlled cross-over trial. Int J Mol Sci. 2025, 26:2479. 10.3390\/ijms26062479","journal-title":"Int J Mol Sci"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1569733","article-title":"Roles of LRRK2 and its orthologs in protecting against neurodegeneration and neurodevelopmental defects","volume":"13","author":"Nguyen AP","year":"2025","unstructured":"Nguyen AP, Nguyen LT, Stokke BA, Quinn CC. Roles of LRRK2 and its orthologs in protecting against neurodegeneration and neurodevelopmental defects. Front Cell Dev Biol. 2025, 13:1569733. 10.3389\/fcell.2025.1569733","journal-title":"Front Cell Dev Biol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-023-02390-8","article-title":"Age of onset of obsessive-compulsive disorder differentially affects white matter microstructure","volume":"29","author":"Vriend C","year":"2024","unstructured":"Vriend C, de Joode NT, Pouwels PJ, et al.. Age of onset of obsessive-compulsive disorder differentially affects white matter microstructure. Mol Psychiatry. 2024, 29:1033-45. 10.1038\/s41380-023-02390-8","journal-title":"Mol Psychiatry"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-023-02043-w","article-title":"The synaptic hypothesis of schizophrenia version III: a master mechanism","volume":"28","author":"Howes OD","year":"2023","unstructured":"Howes OD, Onwordi EC. The synaptic hypothesis of schizophrenia version III: a master mechanism. Mol Psychiatry. 2023, 28:1843-56. 10.1038\/s41380-023-02043-w","journal-title":"Mol Psychiatry"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/474557-a-developmental-taxonomy-of-autism-and-the-precision-timing-of-the-cheung-glutamatergic-regimen","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T23:18:22Z","timestamp":1776295102000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/474557-a-developmental-taxonomy-of-autism-and-the-precision-timing-of-the-cheung-glutamatergic-regimen"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":33,"URL":"https:\/\/doi.org\/10.7759\/cureus.107120","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,15]]}}}